Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this study is to assess the safety profile of RCS-01 injections as compared to placebo injections. This study will also measure the impact these injections will have on skin markers related to aging through evaluation of gene expression profiles.

30 participants will be selected for this study based on their health status, current/past medications, and ability to adhere to protocol-related requirements. At the first visit and after providing informed consent, participants are evaluated against the study inclusion/exclusion criteria and provide blood samples for screening assessments (including virology). If suitable for study participation, participants will provide a biopsy from the scalp from which RCS-01 will be prepared and will have four treatment evaluation sites identified on their buttocks, two on each side.

Study participants will be randomized to one of two treatment subgroups. Participants in the RCS-01 Subgroup (n=24) will receive injections of RCS-01 or placebo or a 'sham' injection (a needle penetration without injection of liquid). Participants in the the Placebo Subgroup (n= 6) will be randomized to receive only injections of placebo or sham injections.

Baseline evaluations of subjects' overall health and skin condition at treatment sites on their buttocks will be performed before receipt of injections at Day 0. In addition to injections delivered at Day 0, the pre-selected treatment evaluation sites will receive intradermal injections of RCS-01 or placebo (cryomedium) or a sham injection four (4) and eight (8) weeks after Day 0 according to a randomization schedule for a total of three (3) injections per treatment site.

All participants will return to the clinic for at least 9 visits during the 52-week follow-up period to monitor long-term safety. At the 12-week time point, 18 randomly-selected participants from the RCS-01 Subgroup will provide biopsies from all injection sites for analysis of skin markers related to aging. At the 26-week time point, the remaining participants will provide biopsies of all injection sites for histopathological analysis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02391935
Study type Interventional
Source RepliCel Life Sciences, Inc.
Contact
Status Completed
Phase Phase 1
Start date October 10, 2015
Completion date July 12, 2017

See also
  Status Clinical Trial Phase
Completed NCT04606368 - Bausch Health Thermage FXL for Use on Lower Face and Submentum Area N/A
Completed NCT01205061 - Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds N/A
Completed NCT01205048 - Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds N/A
Completed NCT01029301 - Evaluation of Safety and Efficacy of Using EndyMed Pro Skin Treatment System for Skin Wrinkle Treatment on Body Areas N/A
Completed NCT04861766 - Safety and Effectiveness of STYLAGE® L for Correction of Moderate and Severe Nasolabial Folds in Chinese Adults N/A
Completed NCT00114673 - A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling N/A
Completed NCT00111254 - The Effects of Microdermabrasion on Skin Remodeling N/A
Completed NCT00945685 - Evaluation of Safety and Efficacy of Using Imagineā„¢ Computerized Radiofrequency System for Skin Tightening N/A
Completed NCT05720000 - Use of Red Light Emitting Diode (LED) and Polydioxanone Thread in Glabellar Wrinkles N/A
Completed NCT01732809 - Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses Phase 4
Completed NCT06451822 - Efficacy and Performance Evaluation of mIntense L+AS 25 mg/ml Hyaluronic Acid for the Correction of Moderate to Deep Wrinkles and Folds N/A
Completed NCT00250952 - Study to Determine If the Volume Used to Dilute BOTOX Cosmeticā„¢ for Injection Affects Its Overall Effect and Duration. N/A
Completed NCT03505684 - Effect of Oral Collagen Tripeptide on Skin Moisture and Wrinkles in Adult Women N/A
Completed NCT02832583 - Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With Regen-Kit BCT-HA in Aesthetic Medicine N/A
Completed NCT00113100 - Mechanisms of Skin Repair by Topical Estrogen N/A